CG
EW icon

Carmignac Gestion’s Edwards Lifesciences EW Stock Holding History

Carmignac Gestion’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,172
Closed -$1.1M – 144
2020
Q4 		$1.1M Sell
12,172
-5,435
-31% -$451K 0.01% 116
2020
Q3 		$1.4M Sell
17,607
-15,805
-47% -$1.23M 0.02% 102
2020
Q2 		$2.3M Sell
33,412
-1,458,689
-98% -$104M 0.03% 86
2020
Q1 		$93.8M Buy
+1,492,101
New +$108M 1.6% 24

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Carmignac Gestion's EW Position: Q1 2021 in Review

Carmignac Gestion sold out of Edwards Lifesciences (EW) in Q1 2021, closing a stake of 12,172 shares — an estimated $1.1M sold.

Carmignac Gestion first reported a position in EW in Q1 2020 and held it in 4 quarters. The position peaked at $93.8M in Q1 2020. 1,143 funds tracked by Wall St. Rank hold EW as of Q1 2021.

  • Carmignac Gestion reported no remaining Edwards Lifesciences position as of Q1 2021 after selling out during the quarter.
  • Carmignac Gestion sold 12,172 Edwards Lifesciences shares in Q1 2021, an estimated $1.1M.
  • Carmignac Gestion first reported a position in Edwards Lifesciences in Q1 2020 and held it in 4 quarters.
  • Carmignac Gestion's Edwards Lifesciences position peaked at $93.8M in Q1 2020.
  • 1,143 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2021.

Based on Carmignac Gestion's 13F filing for Q1 2021, filed 14 May 2021.